European Pharmaceutical Review Issue 1 2021
Posted: 15 February 2021 | European Pharmaceutical Review | No comments yet
In this issue we discuss whether clinicians know enough about the development of biosimilars to buy in, explore the biggest M&A trends in pharma and what to expect this year and consider the importance of disaccharides in the stabilisation of biologics. The journal also features articles on the fundamentals of contemporary supply chain management and how COVID-19 has impacted oncology drug development.
Also in issue 1:
- FORMULATION, DEVELOPMENT & DELIVERY
Promising biocompatible and biodegradable drug nanocarriers for cancer treatment and bone defect repair
Ying-Jie Zhu, Chinese Academy of Sciences, and Tsun-Kong Sham, University of Western Ontario - MANUFACTURING, PACKAGING & LOGISTICS
Regulatory challenges and myths in pharmaceutical 3D printing
Prachi Khamkar and Atul Kadam, Shree Santkrupa College of Pharmacy - BIOPROCESSING & BIOPRODUCTION
Manufacturing of CAR T-cell therapies
Maciej Nakoniecznik, University College London - METABOLOMICS
Microbiome therapeutic development boosted by metabolomics
Christopher Ford, Seres Therapeutics - QA/QC & ANALYTICAL TECHNIQUES
Effect of moisture variation on the robustness of NIR spectroscopy-based calibration models
Derya Cebeci, PortMera Corp
Established and new mass spectrometry applications to drug discovery and development
Ioannis Papayannopoulos, Celldex Therapeutics - BREXIT
New regulatory landscape for biosimilars in the UK and EU post Brexit transition period
Marie Manley and Chris Boyle, Sidley Austin
The rest of this content is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
